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a b s t r a c t
Recent declines in malaria burden in many parts of the world have prompted consideration of how inter-
ruption of Plasmodium falciparum transmission could be maintained, if achieved, and notably whether
large-scale vector control could be replaced with surveillance. This information is essential for elimina-
tion feasibility assessments and planning. The risk of re-establishment of transmission depends mainly
on vectorial capacity (receptivity), likely to rebound once vector control is removed, the rate of impor-
tation of infections (vulnerability), the capacity to detect and treat infections and the level of immunity
in infected individuals. Timely detection and removal of new infections is likely to be critical to prevent
re-establishment of transmission. We assess, through mathematical modeling and simulation, which
levels of case detection and treatment (case management) are required to prevent re-establishment oflimination transmission of P. falciparum after local interruption of transmission has been achieved, in settings with
varying receptivity and vulnerability. We ﬁnd that, even at rather low levels of receptivity, case manage-
ment alone cannot reliably prevent re-establishment of P. falciparum malaria transmission in the face of
medium to high importation rates. Thus, if vector control is to be discontinued, preventing the importa-
tionsby controlling transmission in source areaswill generally benecessary forpreventing reintroduction
ot bein such settings, and cann
ackground
Recent years have seen remarkable decreases in morbidity
nd mortality due to Plasmodium falciparum malaria in a range
f settings across Sub-Saharan Africa. These decreases have been
chieved primarily by the application of effective vector control
ools, such as indoor residual spraying (IRS) and insecticide-treated
ets (ITNs), and the introduction of artemisinin combination thera-
ies (ACTs) (Barnes et al., 2009; Bhattarai et al., 2007; Ceesay et al.,
008). Such successes,whichhavebeenmadepossible by increased
onor commitment to malaria control, have prompted national
ealth policy-makers and their partners to consider how inter-
uption of transmission could be maintained, if achieved (Malaria
limination Group, 2009).
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Evidence suggests that in some areas with a relatively low
endemicity, local transmission could be (Hay et al., 2008), or may
already have been (John et al., 2009), interrupted. In such places,
for example the Kenyan highlands and Zanzibar, vector controlwas
critical to bringing about substantial decreases in transmission and
continues to be widely applied. However, it is likely to be difﬁcult
to sustain the will to maintain high levels of these interventions,
particularly after malaria has ceased to be a public health prob-
lem (Feachem and Sabot, 2008). Policy makers will need guidance
on when it is safe to scale down large-scale vector control opera-
tions aimed at achieving interruption of transmission and on when
to proceed with a policy that relies mostly on surveillance. Main-
tenance of transmission interruption without large-scale vector
control has been possible in several areas with moderate endemic-
ity levels, such as Reunion Island (Girod et al., 1995) and Singapore
(Lee et al., 2009). In other places, such as Mayotte in the Comoros
Islands, interruption of P. falciparum transmission has proved elu-
sive even when it seemed imminent, despite intensive control
efforts, and it seems that vector control will need to be main-
tained to prevent resurgence of malaria (Rebaudet et al., 2010).
Understanding malaria resurgence risks is of critical importance to
malaria control programmes when setting objectives and planning
malaria strategies.
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In closed systems, interruption of transmission would be main-
ained automatically once achieved. However, in reality, human
opulations are connected toeachother, andas longas local vectors
ave sufﬁcient capacity to transmit malaria, local transmission can
e reintroduced through immigration of infected people or infec-
ive mosquitoes. The greater the magnitude of this immigration,
he more likely malaria transmission will resurge, all else equal.
vidence indicates that current control strategies, even applied at
ery high coverage, will be insufﬁcient to interrupt transmission
n much of Sub-Saharan Africa (Ferguson et al., 2010), so importa-
ion of infections will remain a major challenge for the foreseeable
uture for countries in the region which seek to maintain local
nterruption of transmission.
Health systems which deploy methods for timely detection and
emoval of imported infections can prevent re-establishment of
ransmission. For instance, Singapore, which reported elimination
f malaria in 1982, saw a large cluster of imported P. falciparum
alaria infections in 2005, but local onward transmission was pre-
ented through early diagnosis, treatment and screening (Kang
t al., 2007). Likewise, in the United States of America, outbreaks of
ocally transmitted malaria have been detected and contained on
everal occasions since certiﬁcation of the country’s malaria-free
tatus (Mali et al., 2010).
Individuals can be infected with malaria, and capable of
ransmitting the disease, without showing clinical symptoms.
ntervention strategies based on case detection and treatment tar-
et individuals with clinical disease, whereas others, such as mass
rug administration or screening and treatment, include individu-
ls without signs of illness. Although the latter types of approaches
ay identify a larger proportion of infections, screening or diag-
osis with methods appropriate for use in the ﬁeld, notably rapid
iagnostic tests or microscopy, may still miss a signiﬁcant number
f infections with low or sub-patent parasite densities (Bousema
t al., 2010; Harris et al., 2010). These types of approaches may
lso be less sustainable long-term, because of their costs and orga-
izational requirements, potential to accelerate development of
rug resistance, and refusal of healthy individuals to participate
n repeated screenings (von Seidlein et al., 2003; von Seidlein and
reenwood, 2003; White, 2008).
After interruption of transmission, individuals’ naturally
cquired immunitywill decay in theabsenceofexposure tomalaria.
lthough the mechanisms involved are poorly understood, this
ecay in immunity couldbe expected to inﬂuence re-establishment
f transmission in two ways. First, an infected individual with
lower anti-parasite immunity is more likely to be infective to
osquitoes. Second, an infected individual with a lowered immu-
ity ismore likely to showclinical symptoms and thus, given access
o appropriate care, to be treated promptly, reducing the parasite
eservoir. Both these effects need to be considered in assessing the
ikely outcomes of different strategies.
The vectorial capacity is the capacity of the combined vec-
or populations present in an area to transmit disease agents,
xpressed as the potential number of inoculations per time unit
riginating from an infective person with no prior immunity. In
he absence of major structural environmental or socio-economic
hanges, it is probable that, after withdrawal of large-scale vector
ontrol operations, the vectorial capacity will revert quickly to the
ame level as prior to control. As the vectorial capacity is difﬁcult to
easure, the pre-intervention entomological inoculation rate (EIR)
ay be a good proxy measure for the receptivity.
The risk that transmission will re-establish in an area thus
epends mainly on the local receptivity, or vectorial capacity, the
ocal vulnerability, or infection importation rate (IIR), the capac-
ty to detect and treat infections, and the level of immunity in
nfected individuals. The purpose of this paper is to assess, through
athematical modeling and simulation, which levels of caseics 4 (2012) 1–8
detection and treatment (case management) are required to pre-
vent re-establishment of transmission of P. falciparum after local
interruption of transmission has been achieved, in settings with
varying receptivity and vulnerability.
Methods
Individual-based stochastic simulation models of the biology
and epidemiology of P. falciparum malaria were developed to study
long-term impacts and cost-effectiveness of intervention strate-
gies, andhave beendescribed elsewhere (Smith et al., 2006a, 2008).
Brieﬂy, there is a simulated population of humanswho are updated
at each ﬁve-day time step via model components representing
new infections, parasite densities, acquired immunity, uncompli-
cated and severe episodes, direct and indirect malaria mortality,
infectiousness to mosquitoes, and case management. Simulated
immunity to asexual parasites, derived from cumulative exposure
to both inoculations andparasite densities andmaternal immunity,
acts mainly by controlling parasite densities (Maire et al., 2006a).
Theprobability of a clinical attackofmalariadependson the current
parasite density and a pyrogenic threshold (Smith et al., 2006b).
Severe malaria comprises two categories of episodes: those that
occur as a result of overwhelming parasite densities, and those
that arise when an uncomplicated malaria episode coincides with
non-malaria co-morbidity.Mortality canbe either direct (following
severe malaria) or indirect (uncomplicated malaria in conjunction
with co-morbidity, or during the neonatal period as a result of
maternal infection) (Ross et al., 2006b). There is also a model of
the dynamics of malaria in mosquitoes (Chitnis et al., 2008).
Infectivity of hosts to mosquitoes at a given time point is mod-
eled as a function of asexual parasite densities 10, 15 and 20 days
previously, allowing for the delay resulting from the time course of
gametocytemia (Ross et al., 2006a). Effective treatment completely
clears parasites by the next time step, ending the infection, while
ineffective treatment has no impact on asexual parasite densities.
By clearing asexual parasites, case management renders individ-
uals uninfectious to vectors at later time points. Given sufﬁciently
high casemanagement coverage, this lowered infectivity translates
into a future reduction in EIR. We do not model the effects of drug
treatment on gametocytemia.
Previous studies using these models (Maire et al., 2006b; Penny
et al., 2008) focused on settings of medium to high transmission
intensity, for which the model outcomes could be presumed to be
insensitive to importation of infections. We have now extended
thesemodels to include importationof infections, andapplied them
to low and medium transmission settings.
We used three different pre-intervention EIRs of two, 20, and 50
inoculations per adult per annum (ibpapa), with a pattern of sea-
sonality asobserved inNamawala, Tanzania (Smithet al., 1993). The
infection status and immune status at the start of the simulation
are determined by exposing the simulated population to the same
annually recurring pattern of inoculations for a lifetime-long burn-
in at the start. The level of case management coverage was set at
zero during the burn-in period in all simulations in order to ensure
that the simulated vectorial capacity was the same across all sce-
narios. Casemanagement coveragewas changed to the appropriate
level at the beginning of the main simulation.
We used a population size of 1000, with underlying demogra-
phy based on East African life tables (INDEPTH Network, 2002). In
our simulations, to interrupt transmission, we applied mass drug
administration at 100% coverage and cleared all infections from
vector mosquitoes over a period of 30 days at the beginning of year
2. These interventions are not intended to be realistic, but were
a convenient way to locally eliminate malaria in our simulations.
Achievement of such high coverage of mass drug administration
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Table 1
Descriptions of model variants and predicted odds ratio that transmission remains interrupted for each model variant relative to the base model, at pre-intervention EIR of
2 and 20 ibpapa.
Model
identiﬁer
Description Half-life of decay (years) Odds ratio,
EIR =2
95% conﬁdence
interval
Odds ratio,
EIR =20
95% conﬁdence
interval
t1/2 = − ln(2)/˛b t1/2 = − ln(2)/˛c
R0125 Fixed decay in immune proxies ∞ 10a 4.57 4.02 5.21 1.47 1.27 1.71
R0132 Estimation of decay in immune proxies ∞ 14 4.31 3.79 4.90 1.29 1.11 1.49
R0115 Fixed decay in effective cumulative
exposure
10a ∞ 4.17 3.67 4.74 1.29 1.11 1.50
R0133 Estimation of both decay parameters 250 19 3.89 3.42 4.42 1.37 1.18 1.59
R0131 Estimation of decay in effective
cumulative exposure
1187 ∞ 2.42 2.14 2.74 1.36 1.17 1.58
R0065 Mass action: Ea(i, t) varies between
and within hosts
∞ ∞ 2.18 1.93 2.47 1.89 1.63 2.20
R0670 Heterogeneity in susceptibility to
comorbidity
∞ ∞ 2.03 1.80 2.30 1.22 1.05 1.41
R0063 Mass action: Ea(i, t) varies mainly
between hosts
∞ ∞ 1.86 1.64 2.10 2.04 1.75 2.37
R0121 Fixed decay in immune proxies ∞ 1000a 1.63 1.45 1.84 1.18 1.02 1.37
R0068 Mass action: Ea(i, t) varies mainly
within hosts
∞ ∞ 1.44 1.27 1.62 1.53 1.32 1.78
R0111 Fixed decay in effective cumulative
exposure
1000a ∞ 1.30 1.15 1.46 1.14 0.98 1.33
R0674 Uncorrelated heterogeneities in access
to treatment and susceptibility to
comorbidity
∞ ∞ 0.63 0.56 0.71 1.04 0.89 1.21
R0678 Heterogeneity in access to treatment ∞ ∞ 0.56 0.50 0.63 0.87 0.75 1.02
Ea(i,t): the expected number of entomological inoculations, adjusted for age and individual factors.
˛
˛
ated.
w
t
c
h
w
ﬁ
b
c
e
C
d
p
c
t
s
i
s
m
t
i
p
f
(
r
f
2
t
t
s
l
o
o
rb: decay applied to the two measures of the effective cumulative exposure.
c: decay applied to the function representing the immune status.
a These parameters were ﬁxed, in other models the decay parameters were estim
ould be nearly impossible in a real-life setting, nor dowe consider
he mechanism by which all infections could be simultaneously
leared from vector mosquitoes.
The casemanagement component (Tediosi et al., 2006)models a
ealth system using ACT. Individuals with uncomplicated malaria
ere assigned a probability of accessing treatment over the next
ve-day period, expressed as percent coverage, which was varied
etween 0% and 100% at 10% intervals. These probabilities were
onstant over the entire time period of the simulation. We consid-
redonly casedetectionand treatmentbasedonclinical symptoms.
ompliance to the drug was set at 90% (Fogg et al., 2004), and the
rugwas assumed to be 98% effective. In patientswho did not com-
ly, thedrugwasassumedtohaveaneffectivenessof20%.All severe
aseswere assigned a probability of receiving treatment as an inpa-
ientof48%, andparasiteswerecleared inall hospitalizedcaseswho
urvived (Tediosi et al., 2006).
Imported infections were simulated by assigning infections to
ndividuals in the population stochastically every 30 days at a con-
tant average rate throughout the simulation period. No infected
osquitoes entered the local system. The rate of imported infec-
ions was Poisson distributed with mean of 0, 0.02, 0.2, 2, or 20
mported infections per 1000 persons per annum. These rates com-
are to estimates of infection importation rates in Zanzibar ranging
rom 2 to 8 infections per 1000 inhabitants per annum in 2008
Malaria Elimination Group, 2009; Tatem et al., 2009) and cases
eported as imported in South Africa from 1981 to 1999 ranging
rom about 0.02 to about 0.17 per 1000 population (Craig et al.,
004). The IIR of 0was includedas a reference scenario to check that
ransmission had indeed been interrupted by mass drug adminis-
ration and clearing infections from vectors.
We evaluated the impact of all possible combinations of these
cenarios on the number of malaria episodes expected over the
ast 14.75 years of the simulations. For each IIR, we chose a thresh-
ld number of cases over the 14.75-year period after interruption
f transmission above which we considered transmission to have
e-established. This threshold was calculated by taking the 97.5Decays shorter than the shortest ﬁxed values gave unacceptable ﬁts to the data.
percentile of the Poisson distribution of the number of imported
cases that would be expected over the period, and multiplying this
by 3, thus allowing each imported infection to give rise to a maxi-
mum of 2 secondary infections before classifying the simulation as
one where transmission was re-established. The reason for using
the 97.5 percentile was to establish a very generous threshold for
re-establishment. If malaria is considered to have re-established
under these conditions, it is not likely to be kept out under more
strict deﬁnitions.
We assessed the uncertainties in model predictions resulting
from stochastic variation and from the assumptions in our model
formulations by using 100 different seeds for the random number
generator and an ensemble of 14 model variants as described in
Table 1. The ensemble consists of a base model, used in previous
publications (Maire et al., 2006b; Penny et al., 2008), and thirteen
variants on that model, with each one representing a different set
of assumptions about malaria transmission and epidemiology. The
motivation for using model ensembles is to assess how our under-
standing of a particular phenomenon is affected by uncertainty in
model assumptions. Our ensemble of stochastic simulation mod-
els of malaria epidemiology incorporates different assumptions
about decay of immunity and about heterogeneities in exposure,
co-morbidity and access to treatment (Smith et al., in press).
While the base model assumes that, in a given transmission
setting, entomological exposure depends only on age, the model
variants for heterogeneities in exposure include random varia-
tion in the availability of the human host to mosquitoes. Thus,
the expected number of entomological inoculations is additionally
a function both of the individual and of log-normal noise. Three
different parameterisations were considered—R0063 assigns most
variation to be inter-host, R0068 assigns the variation predomi-
nantly to within host variation, and R0065 is intermediate.The model for natural immunity used in the base model, devel-
oped primarily for simulating the epidemiology of malaria in
endemic settings, does not allow for any decay of immunity in the
absence of exposure. To allow for such decay, the base model was
4 V. Crowell et al. / Epidem
Figure 1. Simulated clinical incidence by model variant with 20% (a) and 80% (b)
case management coverage, at IIR =2 per 1000 persons per annum, and at a pre-
intervention EIR of 2 ibpapa. Black lines: model variant medians; gray shading: 95%
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f seasonality. The arrow indicates the time pointwhere transmission is interrupted
ith mass drug administration and clearing infections from vectors.
xtended by two alternative algorithms. In both cases, the model
ariants were parameterised so that in the absence of new expo-
ure, the decayed value is some ﬁxed proportion of that at the
revious ﬁve-day time step. The half life of the decay is either ﬁxed
t 10 or 1000 years or estimated during the model ﬁtting process.
Finally, the model variants for heterogeneities in co-morbidity
nd access to treatment assign each simulated individual a status
or each of the two kinds of heterogeneity at birth, which they carry
hroughout their life, structured in each case so that 50% of the
opulation are assigned to each of the high and low status cate-
ories, with the values in the base model multiplied by either 1.8
r 0.2. Two of the model variants simulate these heterogeneities
ingly, while the third simulates both, where they are assigned to
ndividuals independently of each other.
Analyses were conducted using R statistical software version
.11.1 (R Development Core Team, 2010).
esults
Fig. 1 illustrates the use of model ensembles to simulate clin-
cal episodes over time, in a setting with a pre-intervention EIR
f 2 ibpapa. Model variant medians for simulated incidence post-
ntervention were higher at 20% (a) case management coverage
han at 80% (b), indicating the effect of higher case management
overage in reducing transmission. In these scenarios, where IIR =2
er 1000 persons per annum, the higher case management cover-
ge level seems to prevent the resumption of transmission in most
imulations, in contrast to the lower case management coverage
evel. There was a much larger variation among model variant out-
omes post-intervention at the lower case management coverage
evel.
Fig. 2 depicts the proportion of model variant simulations in
hich transmission remained interrupted as a function of case
anagement coverage at different IIRs. In the lowest transmis-
ion setting with a pre-intervention EIR of 2 ibpapa (Fig. 2a), there
as a positive relationship between case management coverage
nd the proportion of simulations in which transmission remainedics 4 (2012) 1–8
interrupted for all IIR levels except at 0.02 imported infections
per 1000 persons per annum. At IIR =0.2 per 1000 persons per
annum, 60% case management coverage resulted in maintenance
of interruption of transmission in 86% of simulations of the median
model variant. At IIR =2 and 20 per 1000 persons per annum, pre-
dicted success was much lower; at IIR =2, at 60% case management
coverage, transmission remained interrupted in only 66% of simu-
lations of the median model variant, while at IIR =20, transmission
remained interrupted in only 15% of simulations of the median
model variant at 60% case management coverage. At IIR =0.2 and 2
per 1000 persons per annum, most of the beneﬁts from increasing
case management coverage seem to be gained at lower coverage
levels; at 70% case management coverage, the imaginary curve
through the median model variant results ﬂattens off. As seen from
the boxplot, variation in probability of success over the model vari-
ants was relatively large at the IIR levels 2.0 and 20. At the lowest
IIR, 0.02 per 1000 persons per annum, case management coverage
level had little effect on the probability of success; however, at this
low IIR level, the probability that no infections were imported dur-
ing the observation period in a simulation was 74%. At IIR =0.2 per
1000 population per annum, this probability was approximately
5%.
In the higher transmission settings (Fig. 2b and c), at IIR =0.2
per 1000 persons per annum, higher case management cov-
erage slightly increased the proportion success in preventing
re-establishment, but even with perfect passive case detection,
transmission returned in at least half of simulations of the median
model variant. In these settings, at IIR =2 or 20per 1000persons per
annum, interruption of transmission was never, or almost never,
maintained.
Fig. 2 primarily serves to show the trends among case man-
agement coverage, IIR, and the proportion of simulations in which
transmission remained interrupted, and where most model vari-
ants agreed and where there was a wider range in predictions. The
median proportion of simulations in which transmission remained
interrupted may be biased and should not be over-interpreted, as
it is unclear how to weight the fourteen model variants to allow for
plausibility, goodness of ﬁt and correlations both in structure and
parameter values.
In general, at low case management coverage, the model vari-
ants for heterogeneities in exposure resulted in a higher proportion
of simulations in which transmission remained interrupted. At
medium to high case management coverage, it was the decay of
immunity model variants which resulted in a higher proportion.
The model variants with heterogeneities in access to treatment
usually resulted in a lower proportion of simulations in which
transmission remained interrupted.
For each pre-intervention EIR, we ﬁtted a logistic regression
model to the probability of success in preventing re-establishment
of transmission, with covariates in case management coverage,
the natural logarithm of the infection importation rate, and each
of the fourteen model variants as categorical variables. Backward
stepwise regression showed that removing any of the indepen-
dent variables from the model was found to signiﬁcantly decrease
the model’s goodness of ﬁt at the 95% conﬁdence level, so all
covariates were kept. We then tested for interaction between case
management coverage and the natural logarithm of the infection
importation rate. From the likelihood ratio test, the interaction
term was found to be signiﬁcant (p<0.001), although it has only
a slight effect.
The ﬁtted relationships between case management coverage
and the probability that transmission remains interrupted, for the
base model and at different IIRs, are shown in Fig. 3a (EIR =2
ibpapa) and Fig. 3b (EIR =20 ibpapa). The ﬁgure at EIR =50 ibpapa
looks very similar to that at EIR =20 ibpapa and is not shown. At
EIR =2 ibpapa, the odds ratio that transmission remains interrupted
V. Crowell et al. / Epidemics 4 (2012) 1–8 5
1.
0
0.
8
0.
6
0.
4
0.
2
0.
0
1.
0
0.
8
0.
6
0.
4
0.
2
0.
0
1.
0
0.
8
0.
6
0.
4
0.
2
0.
0
a
b
1009080706050403020100
c
Case Management Coverage (%)
P
ro
po
rt
io
n 
su
cc
es
s 
in
 p
re
ve
nt
in
g 
re
es
ta
bl
is
hm
en
t
F ) of th
v d at a
w ted in
a
A
2
m
h
o
m
r
R
f
t
(
o
m
r
v
t
r
D
w
g
aigure 2. Boxplot (with the median, maximum, minimum, and interquartile ranges
ariant, at each case management coverage level and infection importation rate an
hite: IIR =0.02, light gray: IIR =0.2, medium gray: IIR =2, dark gray: IIR =20 impor
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t EIR =20 ibpapa, the corresponding odds ratio is 23.7 (95% CI:
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Table 1 shows that, at a pre-intervention EIR of 2 ibpapa, the
odel variants which included decay of immunity with a shorter
alf-life were found to have a relatively large positive effect on the
dds that transmission remained interrupted relative to the base
odel. By contrast, model variants R0674, which assumes uncor-
elated heterogeneity in co-morbidity and access to treatment, and
0678, which assumes heterogeneity in access to treatment, were
ound to have a relatively large negative effect on the odds that
ransmission remained interrupted relative to the base model.
At the higher pre-intervention EIRs of 20 ibpapa and 50 ibpapa
not shown), the model variants had much smaller effects on the
dds that transmission remained interrupted relative to the base
odel. This is evidenced by the much narrower range in the odds
atios. Moreover, in these transmission settings, it was the model
ariants that assumed heterogeneity in entomological exposure
hat had the largest positive effects on the odds that transmission
emained interrupted.
iscussionAlthough maintaining interruption of malaria transmission
ould bring beneﬁts, it would also require reorientation of pro-
rammatic strategies, signiﬁcant long termﬁnancial commitments,
nd major operational preparations. Therefore, the decision toe proportion of simulations in which transmission remained interrupted, by model
pre-intervention EIR of 2 ibpapa (a), 20 ibpapa (b) and 50 ibpapa (c). Fill colours:
fections per 1000 per annum.
pursue transmission interruption and prevention of re-
establishment of transmission is not trivial. Prior to embarking on
such a course a thorough evaluation of the likelihood of success,
and what will be required to maintain it, is desirable.
Early detection and treatment of infections is critical to pre-
vent onward transmission in the face of renewedvectorial capacity.
However, our ﬁndings also suggest that, even where vectorial
capacity is low, maintaining interruption of transmission is likely
to require continued vector control at or above moderate levels
of vulnerability (IIRs on the order of 0.2 per 1000 population per
annum or higher). Even perfect passive case detection will fail
to identify imported asymptomatic infections, which under these
circumstances will be sufﬁciently numerous to result in a consid-
erable probability of resumption of transmission. The chances that
an imported infection is asymptomatic will depend on the immu-
nity proﬁle of the immigrant/visitor, which in these analyses was
assumed to match that of the simulated population.
Statistical analysis revealed that modeled outcomes were sen-
sitive to several of the model assumptions. At low pre-intervention
EIR levels, decay of natural immunity is an important driver of
whether or not interruption of P. falciparum malaria transmission
canbemaintained. This is because, as immunitydecays,more infec-
tions are likely to be symptomatic, and therefore detectable and
treatable by the passive case management system. Also, in the
base model, individuals are assumed to have homogenous access
to treatment and to be at similar risk of co-morbidity. In this anal-
ysis, introducing heterogeneities in these factors increased the risk
6 V. Crowell et al. / Epidem
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Figure 3. (a and b) Best-ﬁtting regressionmodel predictions for the probability that
transmission remains interrupted, as a function of case management coverage and
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f re-establishment. These ﬁndings suggest that areas with these
inds of differentials among population sub-groups may face spe-
iﬁc challenges in maintaining transmission interruption.
In higher transmission settings, variations in these assump-
ions did not have as large an effect on the odds that transmission
emained interrupted. At higher pre-intervention EIRs, the vecto-
ial capacity is the dominant determinant of re-establishment. In
hese settings, immunity was much higher post-interruption than
n the low-transmission setting, and thus even with decay, a large
umber of infections remain asymptomatic.
The perhaps counter-intuitive ﬁnding that themodels assuming
eterogeneity in force of infection had positive effects on the odds
hat transmission remained interrupted could be explained in sev-
ral ways. First, if infections are concentrated in the same people,
given level of case management coverage will result in a higher
roportion of infections being treated than if infections are spread
ore evenly across the population (because a single treatment will
erminate all co-infections in that host). Second, this ﬁndingmaybe
ue to the way we have constructed our outcome variable. Where
ertain individuals have higher availability tomosquitoes than oth-
rs, this may result in a lower number of episodes (as multiple
nfections can give rise to only one episode at a time).
There are several factors that are likely to affect the probability
f success in preventing re-establishment which were not consid-
redhere. Characteristics of thepopulationunder consideration, for
xample the size of the population and the degree of interaction
etween individuals, were not studied. Interruption of transmis-
ion is easier to achieve and maintain in smaller populations than
n large ones, ceteris paribus, as re-introduction of transmission is
n infrequent, and hence highly stochastic, event. Our results, using
population of 1000, therefore offer an optimistic estimate of the
robability for prevention of re-establishment, and make predic-
ions at very low IIRs problematic. Also, our models assume perfect
ixing within each mosquito population across all humans. Patchics 4 (2012) 1–8
models may offer a way forward to more accurately capture the
phenomena of heterogeneity in interactions, as well as spatial het-
erogeneity in transmission.
The probability that transmission remains interrupted or con-
versely, re-establishes, is also likely a function of geographical and
temporal heterogeneities in importation of infections. We assume
that imported infections mix uniformly with the simulated popu-
lation and enter at a constant rate; however, in reality, individuals
bringing malaria infections into an area may concentrate in a par-
ticular place. If this effect is important, we expect transmission
to spread more slowly, and to be easier to arrest, provided that
such foci can be located. Also, rates of case importation may not be
constant over time. Our models could incorporate this, but reﬁn-
ing these assumptions would require temporal data on human
migration patterns. This is an important area of further research
(Rebaudet et al., 2010; Tatem and Smith, 2010).
Our rapid method of interrupting transmission likely had an
effect on chances of maintaining interruption, as even with the
model variants which capture immunity decay, immunity levels
remained relatively high in the population for a certain time. In
reality, interruption of transmission would take longer and immu-
nity would be lower upon its achievement, resulting in a higher
proportion of secondary (locally transmitted) infections manifest-
ing clinically. The level of immunity in the population at the time
of interruption, which drives the proportion of infections in the
population which are asymptomatic, is an important determi-
nant of the probability of success in preventing re-establishment.
This may lead our models to overestimate the probability of re-
establishment of transmission.
On the other hand, our method of importing infections may
have led us to underestimate the probability of re-establishment
of transmission. We assign imported infections randomly to indi-
viduals in the simulated population, who are exposed to the same
transmission and therefore have the same immunity proﬁle. How-
ever, it is likely that transmission in source areas is substantially
higher than in the simulated population, and thus individuals
importing infections would be expected to have higher immu-
nity. Our current models do not offer the possibility to simulate
this immunity differential readily; however, if this were the case
we could expect a lower probability that imported infections are
symptomatic and therefore detectable by the case management
system.
There is a need to extend these models to capture other fea-
tures of real health systems (Checchi et al., 2006; Kiszewski and
Teklehaimanot, 2004; Najera et al., 1998). It would be important
to assess the importance of the capacity of the system to react to
outbreaks by temporarily improving casemanagement coverage or
by implementing emergency vector control operations when out-
breaks occur. In countries which succeed in actively interrupting
transmission, the health systemwill likely have strong surveillance
and epidemic response capacity, which could contain outbreaks
and reduce local transmission again to zero. Screening of potential
asymptomatic carriers would likely be a part of this response and
wasnotmodeledhere. It is alsopossible that, following interruption
of transmission, the case management system would be strength-
ened to enable more intensive routine detection of cases. Under
these conditions, interruption of transmission would be more
likely to be maintained, but probability of success would, again,
depend to a great degree on the immunity proﬁle of the population
concerned.
The case management model offers a very simple description of
the health system and does not consider diagnosis, provider prac-
tices or patient behaviour which could alter coverage. For a better
understanding of the role of case management in achievement and
maintenance of transmission interruption, a more realistic case
management model is needed.
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Thus, there remains a signiﬁcant unﬁnished research agenda
o increase the understanding of the relationship between case
anagement coverage, vulnerability, receptivity and prevention of
e-establishment of P. falciparum malaria transmission. Neverthe-
ess, we believe that the results described here provide important
nput into the discussions surrounding the feasibility of maintain-
ng interruption of malaria transmission in various contexts.
onclusion
Even at rather low levels of receptivity, case management alone
annot reliably prevent re-establishment of P. falciparum malaria
ransmission in the face of medium to high importation rates, even
f all clinical cases are treated. Thus, if vector control is to be discon-
inued, preventing the importations by controlling transmission in
reas fromwhich imported casesoriginate is aprecondition forpre-
enting reintroduction in such settings. Achieving very high levels
f casemanagement coveragedoesnot appear to substitute for this.
lternatively, a system of active surveillance to prevent importa-
ion, including screening of all potential carriers at points of entry,
ould be considered, but in most areas this strategy is not likely to
e feasible.
Model variants assuming decay of natural immunity resulted in
ower odds of transmission re-establishment, relative to the base
odel that assumed no such decay. These ﬁndings highlight the
rgent need for research into the mechanisms and rate at which
aturally acquired immunity to P. falciparum malaria decays in
he absence of exposure, to inform current and future malaria
limination efforts. Certain characteristics of thepopulation, in par-
icular heterogeneities in co-morbidity and access to treatment,
lso appeared to inﬂuence simulated probability of success. There
s a need for further analysis of effects of different population sizes
nd patterns of within-population interaction and of geographical
nd temporal heterogeneity of imported infection rates.
A key issue that has not been addressed here is the related
conomic analysis. Interruption of transmission and prevention
f re-establishment, whether through increased case management
overage or other strategies,will carry signiﬁcant costs,whichneed
o be evaluated together with appropriate outcome measures and
ompared to other possible uses of funds to optimize resource use.
recent study found thatmalaria elimination is unlikely to be cost-
aving in most cases, even over a time frame of 50 years, but may
ring additional beneﬁts that would make it a worthy investment
Sabot et al., 2010).
The costs and effects of screening asymptomatic individuals,
ither in response to a detected case or indiscriminately in at-
isk populations, will likely need to be considered in addition to
ase management. Data from ﬁeld studies are needed to deter-
ine the most cost-effective surveillance and response models in
ifferent settings and to inform future modeling efforts (Moonen
t al., 2010). Importantly, the costs of surveillance are unlikely to
ncrease linearly with coverage; isolated or marginalized popula-
ions are usually the last to be reached and the most expensive to
erve, resulting in signiﬁcant diseconomies of scale at the higher
overage levels. In addition, the appropriate outcome measure to
se in settings where malaria burden is already very low, as would
e the case in places which are close to or have recently achieved
limination, is unclear. Further methodological developments to
uantify the beneﬁts of transmission interruption are needed to
pply economic evaluation usefully.
The results of these analyses need to be taken into account in
lobal and national discourse and in feasibility assessments of and
lanning for elimination of malaria (Malaria Elimination Group,
009). Failure to plan for prevention of re-establishment could
esult in loss of the last decade’s tremendous gains towards rolling
ack malaria.ics 4 (2012) 1–8 7
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